Tanziela Tanziela | Drug Delivery | Innovative Research Award

Innovative Research Award

Tanziela Tanziela
Shandong Xiehe University

Tanziela Tanziela
Affiliation Shandong Xiehe University
Country China
Scopus ID 57219011913
Documents 10
Citations 211
h-index 5
Subject Area Drug Delivery
Event World Cell Biologist Awards
ORCID 0000-0002-7991-9620

Tanziela Tanziela of Shandong Xiehe University is a researcher with a focus on drug delivery. The profile presents the supplied academic information in the context of scholarly output, citation activity, research specialization, and the broader objectives of the World Cell Biologist Awards. The Innovative Research Award recognizes research that demonstrates originality, methodological development, and meaningful potential to contribute to scientific knowledge.[1]

Abstract

Tanziela Tanziela is affiliated with Shandong Xiehe University and is identified in the supplied academic profile with a specialization in drug delivery. The reported research record comprises 10 documents, 211 citations, and an h-index of 5. These indicators provide a quantitative overview of scholarly activity and research visibility, while the subject-area designation places the work within a field concerned with the design, development, characterization, and application of systems for delivering therapeutic agents. The Innovative Research Award profile therefore considers both documented research activity and its relevance to scientific innovation.

Keywords

Innovative Research Award; Tanziela Tanziela; Drug Delivery; Drug Delivery Systems; Pharmaceutical Research; Research Innovation; World Cell Biologist Awards

Introduction

Drug delivery research addresses the challenge of transporting therapeutic compounds to appropriate biological sites while improving delivery efficiency, stability, controlled release, and therapeutic performance. Advances in this area may involve formulation science, biomaterials, nanotechnology, pharmacological approaches, and targeted delivery strategies. Scholarly evaluation commonly combines qualitative assessment of research contributions with bibliometric indicators such as publications and citations. Scopus provides author-level bibliographic and citation information that can be used as one source for evaluating scholarly visibility. [1]

Research Profile

The researcher profile supplied for this article identifies Tanziela Tanziela as affiliated with Shandong Xiehe University in China. The principal subject area is listed as Drug Delivery. The profile reports 10 documents, 211 citations, and an h-index of 5. These values should be interpreted as profile-level indicators that may change as databases are updated and new publications or citations are indexed. [1]

Research Contributions

The supplied subject classification places Tanziela Tanziela’s research within drug delivery, an interdisciplinary area that connects pharmaceutical science with biological and materials-based approaches. Research in this field may investigate how therapeutic compounds are formulated, transported, released, protected from degradation, or delivered to specific biological environments. The researcher profile can therefore be considered relevant to scientific work involving drug-delivery mechanisms and related biomedical applications. [2]

Publications

The supplied profile records 10 documents associated with the Scopus author identifier 57219011913. Because publication metadata, indexing status, citation counts, and author profiles can change over time, individual publication details should be verified against the relevant bibliographic database before formal use in a curriculum vitae, award dossier, or institutional record. [3]

Research Impact

The reported citation count of 211 and h-index of 5 indicate measurable scholarly attention to the indexed publication record. Citation indicators can assist in assessing research visibility, but they should be interpreted alongside publication context, field-specific citation practices, career stage, collaboration patterns, and the substantive significance of individual findings. [4]

Award Suitability

The Innovative Research Award is intended to recognize research activity characterized by originality, scientific relevance, and meaningful contribution to a defined area of research. Based on the supplied information, Tanziela Tanziela’s specialization in drug delivery and documented scholarly profile provide a reasonable basis for consideration within an innovation-oriented research recognition framework.

Bibliometric indicators should be treated as supporting evidence rather than as a substitute for peer assessment. The suitability of the researcher for a specific award should ultimately be determined through the applicable nomination, documentation, and review procedures of the World Cell Biologist Awards. [5]

Conclusion

Tanziela Tanziela, affiliated with Shandong Xiehe University, is presented in the supplied profile as a researcher specializing in drug delivery. The reported record of 10 documents, 211 citations, and an h-index of 5 provides a concise quantitative description of scholarly activity and visibility. These indicators, together with the stated research specialization, support consideration within an innovative research recognition context, while a comprehensive award assessment should incorporate direct evaluation of publications, originality, methodological quality, and broader scientific contribution.

References

  1. Elsevier. (n.d.). Scopus author details: Tanziela Tanziela, Author ID 57219011913. Scopus.
    https://www.scopus.com/pages/authors/57219011913
  2. S Li, JX He, Z Zhou, YH Luo, J Zhuang, T Tanziela, et al. (2026). Repurposing Pentacyclic Triterpenoids as Ferroptosis Inducing Agents for Cancer Therapies.
    https://link.springer.com/article/10.1007/s40495-026-00453-2
  3. MI Ahmad, T Tanziela, MZ Ahmad, et al. (2025). Unraveling the contribution of GASA gene family in sunflower under diverse stress conditions.
    https://link.springer.com/article/10.1007/s11033-025-11028-7
  4. JX He, L Li, S Chen, RJ Chen, T Tanziela, et al. (2026). Outsmarting Metastatic Prostate Cancer: Integration of Imaging, Liquid Biopsies and Biomarkers With Artificial Intelligence.
    https://journals.sagepub.com/doi/abs/10.1177/15330338261440434
  5. M Nawaz, A Nawaz, MN Khan, T Tanziela, et al. (2025). Flavonoids being chemo‐preventive agents induce programmed cell death: mechanisms and therapeutic potentials.
    https://onlinelibrary.wiley.com/doi/abs/10.1002/ptr.70018

Ana Figueiras | Cancer Cell Biology | Best Researcher Award

Assist. Prof. Dr. Ana Figueiras | Cancer Cell Biology | Best Researcher Award

Assist. Prof. Dr. Ana Figueiras , Faculty of Pharmacy/University of Coimbra , Portugal

Ana Rita Ramalho Figueiras is an Assistant Professor at the Faculty of Pharmacy, University of Coimbra, Portugal, and a researcher at REQUIMTE/LAQV, focusing on Pharmaceutical Technology. She earned her PhD in Pharmaceutics from the University of Coimbra in 2009, specializing in drug delivery systems, particularly for cancer treatments. Throughout her career, Ana has worked on advancing the development of block copolymers and micellar systems for targeted drug delivery. With a strong academic background and international exposure, she has contributed significantly to the fields of pharmaceutics, drug formulation, and pharmaceutical sciences. Ana’s work has been recognized through various publications in top journals, and she is deeply involved in mentoring post-doctoral researchers. Her expertise and leadership in pharmaceutical research continue to influence the development of innovative therapies in the pharmaceutical field.

Publication Profile: 

Orcid

Strengths for the Award:

Ana Rita Ramalho Figueiras is a highly accomplished researcher in pharmaceutical sciences, with extensive contributions to drug delivery systems, particularly focusing on micellar systems and polymeric micelles for cancer therapy. Her interdisciplinary work bridges pharmaceutics, chemistry, and biomedicine, showcasing her ability to innovate within drug delivery mechanisms for complex diseases. As an Assistant Professor at the University of Coimbra and an integrated member of the REQUIMTE/LAQV research group, she brings a wealth of academic and research leadership to her field.

Her innovative contributions have been recognized with various academic awards, including distinctions for oral communications and publications. Additionally, she has made substantial contributions to numerous collaborative research projects, focusing on the development of novel therapeutic strategies and drug delivery systems that target poorly soluble drugs, cancer therapies, and chronic diseases like Alzheimer’s.

Areas for Improvement:

While Figueiras is a leading figure in the scientific community, expanding her outreach to a broader range of international research collaborations could further amplify her impact. Although her work on drug delivery systems has significant potential for clinical applications, there could be further focus on translating her findings from bench to bedside by collaborating with clinical researchers for clinical trials and regulatory studies. A stronger emphasis on commercialization of her research could also be beneficial for broader societal impact.

Education:

Ana Rita Ramalho Figueiras pursued her academic journey in the field of Pharmaceutical Sciences, beginning at the University of Coimbra in Portugal. She graduated with a degree in Pharmaceutical Sciences in 2002, followed by a PhD in Pharmaceutics at the same university in 2009. Her doctoral research was focused on enhancing drug solubility and permeability, with a specific focus on cyclodextrins and mucoadhesive polymers for buccal drug delivery. During her PhD, she gained international exposure by collaborating with the University of Santiago de Compostela, Spain, and the University of Innsbruck, Austria. She is also registered as a member of the Ordem dos Farmacêuticos in Portugal since 2003. Ana’s educational foundation, combined with her interdisciplinary collaborations, has provided her with a robust understanding of pharmaceutical sciences and technologies, forming the cornerstone of her impactful career in academia and research.

Experience:

Ana Rita Ramalho Figueiras has been an Assistant Professor at the Faculty of Pharmacy, University of Coimbra, since September 2014, where she is an integrated Ph.D. member in the Pharmaceutical Technology group of REQUIMTE/LAQV. Prior to this, she was an Invited Assistant Professor from 2013 to 2014, working closely with the Center of Neuroscience and Cell Biology (CNC/UC) and contributing as a collaborator in the Health Sciences Research Centre (CICS/UBI). Her academic roles involve teaching, mentoring students and postdoctoral fellows, and leading research projects on advanced drug delivery systems. She has also been involved in supervising several postdoctoral researchers, focusing on developing and characterizing polymeric micellar systems and controlled delivery systems for drugs like pilocarpine. Throughout her career, Ana has participated in various scientific projects, bringing valuable insights into the design of innovative drug delivery platforms with applications in cancer therapy and other medical conditions.

Awards and Honors:

Ana Rita Ramalho Figueiras has received several accolades for her research excellence and contributions to the field of Pharmaceutical Sciences. In 2004, she was awarded a prestigious PhD fellowship by Fundação para a Ciência e Tecnologia (FCT), which enabled her to pursue her doctoral studies. In 2011, she received the Best Short Communication Award at the VI Annual CICS Symposium for her work on new therapeutic strategies for siRNA delivery. In 2012, she was honored with the Best Oral Communication Award for her research on Poloxamine-α-cyclodextrin supramolecular gels promoting osteogenic differentiation of mesenchymal stem cells. These awards underscore her commitment to scientific advancement, as she continues to lead innovative research in drug delivery systems, nanomedicine, and cancer therapy. Ana’s dedication to advancing pharmaceutics has also led her to mentor future generations of researchers, further solidifying her reputation as a leading academic in her field.

Research Focus:

Ana Rita Ramalho Figueiras focuses her research on developing advanced drug delivery systems, specifically in the context of cancer therapies. Her primary research interest lies in utilizing block copolymers and micellar systems for targeted and controlled drug release. This includes the formulation of poorly water-soluble drugs, improving their bioavailability, and creating novel pharmaceutical formulations for effective treatment. Ana is particularly interested in the development of polymeric micelles for the delivery of therapeutic agents, including drugs and genes, to treat various diseases, with a strong emphasis on oncology. Additionally, her research investigates the use of mucoadhesive polymers for drug delivery to mucosal surfaces. With a commitment to improving drug efficacy and reducing side effects, her work aims to enhance patient outcomes through innovative drug formulations. Ana is also involved in several projects that explore natural compounds and their potential for pharmaceutical applications, further contributing to advancements in the drug delivery and pharmaceutical fields.

Publications Top Notes:

  1. “Unraveling Rosmarinic Acid Anticancer Mechanisms in Oral Cancer Malignant Transformation” 🎗️🦷
  2. “Regulation and Safety of Cosmetics: Pre- and Post-Market Considerations for Adverse Events and Environmental Impacts” 💄⚖️
  3. “The Many Faces of Cyclodextrins within Self-Assembling Polymer Nanovehicles: From Inclusion Complexes to Valuable Structural and Functional Elements” 🔬🧪
  4. “Development and Characterization of Curcumin-Loaded TPGS/F127/P123 Polymeric Micelles as a Potential Therapy for Colorectal Cancer” 🍂⚕️
  5. “Pulmonary Delivery of Bacterial Lysates Mediated by Locust Bean Gum Microparticles” 🌬️🦠
  6. “Non-Toxic Mucoadhesive Locust Bean Gum Microparticles for Delivery of Bacterial Lysates to Prevent Respiratory Diseases” 🌱🫁
  7. “Polymersomes as the Next Attractive Generation of Drug Delivery Systems: Definition, Synthesis and Applications” 🧫💊
  8. “Nanotheranostics: The Afterglow for Cancer Immunotherapy” 💡💉
  9. “Acanthus Mollis Formulations for Transdermal Delivery: From Hydrogels to Emulsions” 🌿💧
  10. “A Review of the Application of Ganoderma Lucidum (Curtis) P. Karst. in Nanotechnology for the Treatment of Cancer” 🍄💻

Conclusion:

Ana Figueiras’ expertise in pharmaceutical technology, particularly in the development of polymeric micelles for drug delivery, marks her as an outstanding candidate for the Best Researcher Award. She is an exemplary figure in the realm of pharmaceutics with a strong research focus on improving drug therapies for cancer and other severe diseases. Her work continues to advance drug delivery systems, paving the way for future medical breakthroughs. Figueiras demonstrates a strong foundation in academic excellence, research innovation, and collaboration, positioning her as a leader in her field.